巨噬细胞炎性蛋白3α(MIP3a)活性蛋白

Active Macrophage Inflammatory Protein 3 Alpha (MIP3a)

CCL20; CKb4; LARC; MIP3-A; SCYA20; ST38; Small Inducible Cytokine Subfamily A(Cys-Cys)Member 20; Beta-Chemokine Exodus-1; Liver And Activation-Regulated Chemokine

  • 巨噬细胞炎性蛋白3α(MIP3a)活性蛋白 产品包装(模拟)
  • 巨噬细胞炎性蛋白3α(MIP3a)活性蛋白 产品包装(模拟)
  • APA095Hu02.png Figure. SDS-PAGE
  • 巨噬细胞炎性蛋白3α(MIP3a)活性蛋白 WB图
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

活性实验

Macrophage Inflammatory Protein 3 Alpha (MIP3a) also known as Chemokine (C-C motif) ligand 20 (CCL20) or liver activation regulated chemokine (LARC) is a small cytokine belonging to the CC chemokine family. It is strongly chemotactic for lymphocytes and weakly attracts neutrophils. MIP3a is implicated in the formation and function of mucosal lymphoid tissues via chemoattraction of lymphocytes and dendritic cells towards the epithelial cells surrounding these tissues. It is expressed in several tissues such as peripheral blood lymphocytes, lymph nodes, liver, appendix, fetal lung. Expression of MIP3a can be induced by microbial factors such as lipopolysaccharide (LPS), and inflammatory cytokines such as tumor necrosis factor and interferon-γ, and down-regulated by IL-10. Besides, lnterleukin 1 Alpha (IL1a) has been identified as an interactor of MIP3a, thus a binding ELISA assay was conducted to detect the interaction of recombinant human MIP3a and recombinant human IL1a. Briefly, MIP3a were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 ul were then transferred to IL1a-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-MIP3a pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450nm immediately. The binding activity of MIP3a and IL1a was shown in Figure 1, and this effect was in a dose dependent manner, the EC50 for this effect is 0.676 ug/mL.

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPA095Hu01 巨噬细胞炎性蛋白3α(MIP3a)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA095Hu01 巨噬细胞炎性蛋白3α(MIP3a)活性蛋白 Cell culture; Activity Assays.
RPA095Hu02 巨噬细胞炎性蛋白3α(MIP3a)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA095Hu02 巨噬细胞炎性蛋白3α(MIP3a)活性蛋白 Cell culture; Activity Assays.
PAA095Hu01 巨噬细胞炎性蛋白3α(MIP3a)多克隆抗体 WB; IHC; ICC; IP.
PAA095Hu02 巨噬细胞炎性蛋白3α(MIP3a)多克隆抗体 WB; IHC; ICC; IP.
LAA095Hu71 巨噬细胞炎性蛋白3α(MIP3a)多克隆抗体(生物素标记) WB; IHC; ICC.
LAA095Hu81 巨噬细胞炎性蛋白3α(MIP3a)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
MAA095Hu22 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 WB; IHC; ICC; IP.
MAA095Hu23 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 WB; IHC; ICC; IP.
MAA095Hu24 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 WB; IHC; ICC; IP.
MAA095Hu25 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 WB; IHC; ICC; IP.
MAA095Hu27 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 WB; IHC; ICC; IP.
MAA095Hu21 巨噬细胞炎性蛋白3α(MIP3a)单克隆抗体 WB,IHC
SEA095Hu 巨噬细胞炎性蛋白3α(MIP3a)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA095Hu 巨噬细胞炎性蛋白3α(MIP3a)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.
KSA095Hu01 巨噬细胞炎性蛋白3α(MIP3a)检测试剂盒DIY材料(酶联免疫吸附试验法) 自己动手制作ELISA试剂盒的主要材料

参考文献

杂志 参考文献
Medicine (Baltimore). Increased Serum Levels of Macrophage Inflammatory Protein-3α and Cystatin A Predict a Poor Prognosis of Nasopharyngeal Carcinoma [Pubmed:25396333]
Cancer Serum chemokine network correlates with chemotherapy in non-small cell lung cancer [PubMed: 25976768]
American Journal of Cancer Research CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis. [pubmed:28560063]
Biological Research In vitro chemokine (CC motif) receptor 6-dependent non-inflammatory chemotaxis during spermatogenesis [10.1186:s40659-018-0161-z]
BioMed Research International Indoleamine 2, 3-Dioxygenase (IDO) Regulates Th17/Treg Immunity in Experimental IgA Nephropathy []
留言咨询